Autolus Therapeutics (6A3A) Revenue
Autolus Therapeutics Revenue
Autolus Therapeutics had a revenue of 45.69M in the quarter ending Jun 30, 2026, with 74.27%. This bring the company's revenue in the last twelve months to 117.35M, Increased 26.75%. In the fiscal year ending Dec 31, 2025, Autolus Therapeutics had annual revenue of 75.56M with 646.68% growth.
- Revenue (ttm)
- 117.35M
- Revenue Growth
- 272.71%
- P/S Ratio
- 4.79
- Revenue/Employee
- EUR 100,484
- Employees
- 752
- Market Cap
- EUR 361.72M
Revenue Chart
Autolus Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.56M | 65.44M | 646.68% |
| Dec 31, 2024 | 10.12M | 8.42M | 496.00% |
| Dec 31, 2023 | 1.70M | -4.50M | -72.59% |
| Dec 31, 2022 | 6.19M | 4.69M | 311.02% |
| Dec 31, 2021 | 1.51M | -208.00K | -12.13% |
| Dec 31, 2020 | 1.72M | -1.19M | -41.02% |
| Dec 31, 2019 | 2.91M | 1.86M | 178.19% |
| Sep 30, 2018 | 1.05M | -647.66K | -38.25% |
| Sep 30, 2017 | 1.69M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.